Get started
Author

Javier K. Nishikawa

Observed name: Javier K Nishikawa
ORCID: 0000-0003-3345-9662
Observed ORCID: 0000-0003-3345-9662
OpenAlex ID: A5091848028
Oral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial
2023 · David W. Kimberlin, Inmaculada Aban, et al. · The Journal of Pediatrics · 44
PDF
Congenital Cytomegalovirus Infection and Hearing Loss: It’s Time to Screen
2024 · Javier K. Nishikawa, Pablo J. Sánchez · Otology & Neurotology · 8
“Minimally symptomatic” congenital cytomegalovirus infection: latest data and emerging concepts
2024 · Ashley Howard, Javier K. Nishikawa, et al. · Current Opinion in Pediatrics · 5
Examining Neutropenia During Treatment of Cytomegalovirus Disease in Neonates
2025 · Javier K. Nishikawa, Inmaculada Aban, et al. · The Pediatric Infectious Disease Journal · 4
PDF
Analysis of Vestibular Schwannoma Treatment Experiences on Reddit
2026 · Jeison Chu De Guzman, Javier K. Nishikawa, et al. · Journal of Neurological Surgery Part B Skull Base
Predictors of Neutropenia Secondary to Ganciclovir Exposure During Treatment of Congenital Cytomegalovirus Disease
2024 · Javier K Nishikawa, Inmaculada Aban, et al. · Journal of the Pediatric Infectious Diseases Society
PDF
1753. Neutropenia as a Function of Ganciclovir Exposure During Treatment of Congenital Cytomegalovirus Disease
2023 · Javier K Nishikawa, Inmaculada Aban, et al. · Open Forum Infectious Diseases
PDF
Works count: 7
Citation count: 61
H-index: 4
I10-index: 1
Year
Topic
Type